Abstract: An electronic device includes an operation circuit, a positive input terminal, a negative input terminal, a resistor, and a field effect transistor. The negative input terminal is used for cooperating with the positive input terminal to receive an input voltage. The field effect transistor includes a source connected to the positive input terminal, a drain connected to the operation circuit, and a gate connected to the positive input terminal and the operation circuit via the resistor.

Abstract: An exemplary charging control circuit includes a signal shaping unit, a first switch unit, and a second switch unit. The signal shaping unit receives a control signal, and is capable of reshaping the received control signal to have a time interval transited from a first state to a second state. The first switch unit receives the shaped control signal, and generates a first switching signal. The second switch unit receives the first switching signal, and is capable of being turned on based on the first switching signal for allowing electrical power to be outputted to a battery.

Abstract: The present invention relates to novel metabolites of 5-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}quinoline, which can be useful in treating CNS disorders. The present invention further relates to processes for their preparation, to pharmaceutical compositions comprising them, and to methods of using them.